MENU
BOUT
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

BOUT stock forecast, quote, news & analysis

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index")... Show more

Category: #Mid-Cap Growth
Interact to see
Advertisement
A.I.Advisor
published price charts
BOUT
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for BOUT with price predictions
Oct 21, 2026

BOUT in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 16, 2026

BOUT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 32 of 36 cases where BOUT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BOUT's RSI Oscillator exited the oversold zone, 21 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 58 cases where BOUT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

Following a +1.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where BOUT advanced for three days, in 287 of 346 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BOUT as a result. In 80 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for BOUT turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 38 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BOUT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

The Aroon Indicator for BOUT entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Micron Technology (NASDAQ:MU), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), Lumentum Holdings (NASDAQ:LITE), Teradyne (NASDAQ:TER), Twilio (NYSE:TWLO).

Industry description

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.

Market Cap

The average market capitalization across the CapForce IBD Breakout Opportunities ETF (BOUT) ETF is 105.4B. The market cap for tickers in the group ranges from 718.2M to 1.03T. MU holds the highest valuation in this group at 1.03T. The lowest valued company is PAYS at 718.2M.

High and low price notable news

The average weekly price growth across all stocks in the CapForce IBD Breakout Opportunities ETF (BOUT) ETF was 20%. For the same ETF, the average monthly price growth was 38%, and the average quarterly price growth was 165%. MANE experienced the highest price growth at 20%, while SMTC experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the CapForce IBD Breakout Opportunities ETF (BOUT) ETF was -17%. For the same stocks of the ETF, the average monthly volume growth was 1% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 65
P/E Growth Rating: 60
Price Growth Rating: 47
SMR Rating: 53
Profit Risk Rating: 47
Seasonality Score: 32 (-100 ... +100)
BOUT in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 16, 2026